Lixisenatide protects doxorubicin-induced renal fibrosis by activating wNF-κB/TNF-α and TGF-β/Smad pathways
- Type
- Retraction
- Notice date
- 7/15/2023 0:00
- Journal
- European Review for Medical and Pharmacological Sciences
- Publisher
- Verduci Editore
- Notice DOI
- 10.26355/eurrev_202307_33113
- Original paper DOI
- 10.26355/eurrev_201905_17832